Have you considered switching to Lantus (insulin glargine)?
I already switched to Lantus
Yes, I'm considering switching
No, I'm not going to switch
I already switched from the pump to injections with Lantus
Yes, I'm considering switching from the pump to Lantus
No, I'm sticking with the pump
I don't use insulin
Lantus is not yet available in my country
Have you considered switching to Lantus (insulin glargine)?Poll dates: October 6 - 13, 2002
Total Votes: 631
Lantus® (insulin glargine) is a new, very long acting insulin. It has a remarkably flat action profile that lasts 24 hours, making it an excellent basal insulin. Of injection users who know about Lantus, over 60% have already switched their basal insulin to Lantus, and another 16% are considering it. Interest among pump users is considerably less, with 96% of pump users planning to stick with insulin pump therapy. Only 14% of people who responded were unfamiliar with Lantus. The table below summarizes the responses based on insulin regimen.
278 injection, 234 pump, 512 total
Injection 61% 16% 23% Pump 2% 3% 96% Overall 34% 10% 56%
Compared to the last time we ran this poll in August 2001, about twice as many injection users (61% vs. 34%) report having switched to using Lantus.
Insulin analogs like Lantus, Humalog, and NovoLog offer new choices for people with diabetes who use insulin. Plus, there are even more new insulins on the horizon. If you're unfamiliar with these new insulins, ask your diabetes team about them.
Last Updated: Wednesday March 16, 2005 16:37:14
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2017. Comments and Feedback.